Ligand buys royalty rights in pharmaceutical products and earns income from its Captisol and NITRICIL technology platforms. It last closed at $286.85 on Nov 20, down 0.03% on the day. The next earnings report for LGND is expected around Thu, Feb 25, 2027. For the quarter ended Sep 2026, LGND reported EPS of -$1.43 on revenue of $78.7M, with revenue down 31.8% from a year ago. Over its last 8 reports the stock moved an average of 3.6% the session after earnings. Over the last 12 months LGND insiders bought $0 of stock on the open market and sold $36.5M, according to SEC Form 4 filings.
AI Auto Pilots
Is LGND in one of our AI portfolios?
Five AI traders run real portfolios in the open, with every decision logged. Create a free account to see if they hold LGND.
Close to close, the session after each report, adjusted for splits. Past moves are no guide to the next one.
StreetAlpha callBullish64%
OPTIONS
+2
DARK POOL
+1
HISTORY
0
TECHNICAL
+1
StreetAlpha's call on LGNDStart your 7 day free trial to see StreetAlpha's call before the report, with the options flow, dark pool, history and technical scores behind it.Sign up freeSign in
LGND · as of the Nov 20 close · updated each morning
Pullback inside a longer uptrend
The stock is 7% below its 20 day and 5% below its 50 day average. It is 9% above its 200 day average, so the longer trend is still up. Momentum is weak (RSI 39). The nearest support is the swing low (Aug 7) at $286.65, and the nearest resistance the Pivot at $286.86.
Short trendBearish
Long trendBullish
MomentumWeak
StretchNormal
VolatilityNormal, 4.0%/day
Key levels
$326.6352 week high+13.9%
$307.9520 day average+7.4%
$302.3550 day average+5.4%
$298.98100 day average+4.2%
$291.35Pivot R1+1.6%
$290.41Swing high (Sep 1)+1.2%
$286.86Pivot+0.0%
$286.85Last close
$286.65Swing low (Aug 7)−0.1%
$282.36Pivot S1−1.6%
$260.82200 day average−9.1%
$175.8952 week low−38.7%
Indicators
RSI (14)
38.84
Weak, oversold below 30
Neutral
MACD
-2.93
Below its signal line
Bearish
Stochastic
11.1
Near the bottom of its range
Oversold
ADX (14)
17.5
No clear trend
Williams %R
-89.7
Oversold below −80, overbought above −20
Oversold
CCI (20)
-192.2
Oversold below −100, overbought above 100
Oversold
Rate of change
−6.3%
Change over 10 sessions
Bearish
ATR (14)
$11.36
Typical daily range, 4.0% of price
MA 10Below
MA 20Below
MA 50Below
MA 100Below
MA 200Above
Uptrend
Short trendBullish
Long trendBullish
MomentumFading
StretchNormal
VolatilityNormal, 7.6%/day
Key levels
$326.6352 week high+13.9%
$307.9520 day average+7.4%
$302.3550 day average+5.4%
$298.98100 day average+4.2%
$291.35Pivot R1+1.6%
$290.41Swing high (Sep 1)+1.2%
$286.86Pivot+0.0%
$286.85Last close
$286.65Swing low (Aug 7)−0.1%
$282.36Pivot S1−1.6%
$260.82200 day average−9.1%
$175.8952 week low−38.7%
Indicators
RSI (14)
51.82
Middle of its range
Neutral
MACD
14.78
Below its signal line
Bearish
Stochastic
54.1
Middle of its range
Neutral
ADX (14)
27.1
Trending down
Williams %R
-70.9
Oversold below −80, overbought above −20
Neutral
CCI (20)
-30.9
Oversold below −100, overbought above 100
Neutral
Rate of change
+0.8%
Change over 10 sessions
Bullish
ATR (14)
$21.69
Typical daily range, 7.6% of price
MA 10Below
MA 20Below
MA 50Above
MA 100Above
MA 200Above
What happened before, for LGND
Signal name goes hereSince a recent date
9 times
+0.0%
Signal name goes hereSince a recent date
9 times
+0.0%
Signal name goes hereSince a recent date
9 times
+0.0%
What happened before
See how LGND did after each of today's signals in the past: how often it was higher 10 sessions later, and the typical move, next to its usual record. Free with an account.
November seasonalityHow LGND usually does this month. See Seasonality
Calculated from daily prices after each close. Signals describe the chart, not where the stock will go. Past patterns often fail. Not investment advice.
AI Day Trader
Watch Claude day trade the open, live.
Every session it trades SPY, QQQ, IWM and two daily stock picks, with each call logged before the move.
Whale options flow for LGNDHow many large options trades hit LGND, the bullish and bearish split, and every trade with strike, premium and expiry are shown to AI Starter and AI Pro members.Sign up freeSign in
No whale options trades in LGND in the last 90 days.
From SEC Form 4 filings by LGND's officers, directors and 10% owners. Open market buys and sales only; option exercises, gifts, awards and tax withholding are left out. Not investment advice.
AI Auto Pilots
Paper trading
StreetAlpha runs autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether LGND is in one of them and how their past LGND trades turned out.
From official House and Senate disclosure reports, filed up to 45 days after the trade and shown in dollar ranges. Not investment advice. Use limited by 5 U.S.C. 13107. About this data
About Ligand Pharmaceuticals
Ligand is a biopharmaceutical royalty company based in San Diego, California. It buys and structures royalty interests in medicines that are in clinical development or already on the market, earning income from sales made by partner drugmakers. It also earns royalties and material sales from its Captisol and NITRICIL technology platforms. Its customers are mainly biopharmaceutical companies that develop and sell the medicines tied to its royalty streams.